The effects of medical marijuana laws on potency

被引:81
作者
Sevigny, Eric L. [1 ]
Pacula, Rosalie Liccardo [2 ]
Heaton, Paul [2 ]
机构
[1] Univ S Carolina, Dept Criminol & Criminal Justice, Columbia, SC 29208 USA
[2] RAND Corp, RAND Drug Policy Res Ctr, Santa Monica, CA 90407 USA
关键词
Delta(9)-Tetrahydrocannabinol (THC); Medical marijuana laws; Dispensaries; Sinsemilla; Differences-in-differences; Mediation; CANNABIS PREPARATIONS; LEGALIZATION; IMPACT; MEDIATION; INCREASE; POLICIES; HEROIN; HEALTH; STATES; ABUSE;
D O I
10.1016/j.drugpo.2014.01.003
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Marijuana potency has risen dramatically over the past two decades. In the United States, it is unclear whether state medical marijuana policies have contributed to this increase. Methods: Employing a differences-in-differences model within a mediation framework, we analyzed data on n = 39,157 marijuana samples seized by law enforcement in 51 U.S. jurisdictions between 1990 and 2010, producing estimates of the direct and indirect effects of state medical marijuana laws on potency, as measured by Delta(9)-tetrahydrocannabinol content. Results: We found evidence that potency increased by a half percentage point on average after legalization of medical marijuana, although this result was not significant. When we examined specific medical marijuana supply provisions, results suggest that legal allowances for retail dispensaries had the strongest influence, significantly increasing potency by about one percentage point on average. Our mediation analyses examining the mechanisms through which medical marijuana laws influence potency found no evidence of direct regulatory impact. Rather, the results suggest that the impact of these laws occurs predominantly through a compositional shift in the share of the market captured by high-potency sinsemilla. Conclusion: Our findings have important implications for policymakers and those in the scientific community trying to understand the extent to which greater availability of higher potency marijuana increases the risk of negative public health outcomes, such as drugged driving and drug-induced psychoses. Future work should reconsider the impact of medical marijuana laws on health outcomes in light of dramatic and ongoing shifts in both marijuana potency and the medical marijuana policy environment. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:308 / 319
页数:12
相关论文
共 77 条
[11]   Heterogeneity in the composition of marijuana seized in California [J].
Burgdorf, James Richard ;
Kilmer, Beau ;
Pacula, Rosalie Liccardo .
DRUG AND ALCOHOL DEPENDENCE, 2011, 117 (01) :59-61
[12]   Marijuana Legalization: Lessons from the 2012 State Proposals [J].
Caulkins, Jonathan P. ;
Lee, Michael A. C. ;
Kasunic, Anna M. .
WORLD MEDICAL & HEALTH POLICY, 2012, 4 (3-4) :4-34
[13]   Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence [J].
Cerda, Magdalena ;
Wall, Melanie ;
Keyes, Katherine M. ;
Galea, Sandro ;
Hasin, Deborah .
DRUG AND ALCOHOL DEPENDENCE, 2012, 120 (1-3) :22-27
[14]  
Chapkis W., 2008, Dying to get high: marijuana as medicine
[15]   Impact of South American heroin on the US heroin market 1993-2004 [J].
Ciccarone, Daniel ;
Unick, George J. ;
Kraus, Allison .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2009, 20 (05) :392-401
[16]   MORE ON COMPARING REGRESSION-COEFFICIENTS - REPLY [J].
CLOGG, CC ;
PETKOVA, E ;
CHENG, TW .
AMERICAN JOURNAL OF SOCIOLOGY, 1995, 100 (05) :1305-1312
[17]   Cannabis and anxiety: a critical review of the evidence [J].
Crippa, Jose Alexandre ;
Zuardi, Antonio Waldo ;
Martin-Santos, Rocio ;
Bhattacharyya, Sagnik ;
Atakan, Zerrin ;
McGuire, Philip ;
Fusar-Poli, Paolo .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (07) :515-523
[18]   DECRIMINALIZATION POLICY AND MARIJUANA SMOKING PREVALENCE: A LOOK AT THE LITERATURE [J].
Damrongplasit, Kannika ;
Hsiao, Cheng .
SINGAPORE ECONOMIC REVIEW, 2009, 54 (04) :621-644
[19]  
Davies RB, 2010, ECON SOC REV, V41, P429
[20]   Medical use of cannabis. Cannabidiol: A new light for schizophrenia? [J].
Deiana, Serena .
DRUG TESTING AND ANALYSIS, 2013, 5 (01) :46-51